GoKawiilBiograph-Caristo study finds coronary artery inflammation in 42.9% of low-risk adults
Biograph, a preventive health clinic, completed a U.S. study using Caristo Diagnostics' CaRi-Heart AI technology to assess coronary inflammation in asymptomatic, low-risk individuals. The study found elevated inflammation in 42.9% of participants, including 17.9% with very high inflammation, often in people with no detectable plaque buildup. Standard tests like cholesterol markers, HbA1c, hs-CRP, and the AHA PREVENT-ASCVD calculator showed no correlation with the inflammation findings.
GoKawiil's interpretation of the reporting above, not reported fact.
The findings suggest that conventional blood tests and risk calculators may miss a meaningful share of cardiovascular risk in people who otherwise appear healthy, which could prompt reconsideration of screening protocols for ostensibly low-risk patients. Because the study was conducted by Biograph and used Caristo's proprietary technology, the results also serve as validation and marketing evidence for these companies' diagnostic tools. Broader adoption would likely depend on independent replication and cost considerations for wider clinical use.
- 42.9% of asymptomatic, low-risk adults showed elevated coronary inflammation via AI-powered CT analysis
- 47% of those with no detectable plaque still had elevated perivascular inflammation
- Standard bloodwork and risk calculators showed no correlation with detected coronary inflammation
Source: biograph.com, 2026-10-22
Published there as: “AI analysis of CT scans finds 42.9% of patients have coronary inflammation”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.